BALANCE

A real-world, point-of-care, randomized, parallel group, open, 6-month clinical study to evaluate the effect of a digital disease management tool in patients with type 2 diabetes mellitus

To evaluate the effect of a smart phone- and web portal-based digital disease management tool added to standard care, compared to standard care alone, on glycaemic control in patients with T2DM.

Principal investigators: Dr Calum MacKenzie and Dr Simon Barrett

Number and location of participating sites (by region/ country): UK 20 sites

Funder: Parexel

Start and End date of grant award: 05/2016 to 11/2016

Current Status: Awaiting publication

Contact details / Sponsor: AstraZeneca

Dr. Manish Saxena, William Harvey Heart Centre, Barts and The London School of Medicine & Dentistry, Charterhouse Square, London ECIM 6BQ

Trial Management: Morag MacLean

Clinical Team: Guen Innes/Susan Begg

ECTU involvement: Trial Management, Clinical support – research nurses